Who
Stuart Naylor
Chief Sci Ofcr, Ophthalmology
Company insider
Files Form 4 as: Chief Sci Ofcr, Ophthalmology, MeiraGTx Holdings.
In numbers
- Trades disclosed
- 88
- Buys
- 0
- Sells
- 27
- Bought
- $0
- Sold
- $3.3M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 29 Dec 2018
- Last trade
- 6 Oct 2026
- Last filed
- 6 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Oct 2026filed 6 Oct 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Sold | $294K27,659 at $10.64 | filing |
| 7 Jul 2026filed 7 Jul 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Sold | $35K2,547 at $13.86 | filing |
| 7 Jul 2026filed 7 Jul 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Sold | $374K25,112 at $14.90 | filing |
| 7 Jul 2026filed 7 Jul 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Sold | $35K2,547 at $13.86 | filing |
| 7 Jul 2026filed 7 Jul 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Sold | $374K25,112 at $14.90 | filing |
| 25 Jun 2026filed 29 Jun 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 7 Apr 2026filed 7 Apr 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Sold | $259K27,661 at $9.36 | filing |
| 7 Apr 2026filed 7 Apr 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Sold | $259K27,661 at $9.36 | filing |
| 21 Feb 2026filed 23 Feb 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code M | —25,000 | filing |
| 21 Feb 2026filed 23 Feb 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code F | $88K11,750 at $7.45 | filing |
| 21 Feb 2026filed 23 Feb 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —25,000 at $0.00 | filing |
| 21 Feb 2026filed 23 Feb 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —25,000 at $0.00 | filing |
| 21 Feb 2026filed 23 Feb 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code M | —25,000 | filing |
| 21 Feb 2026filed 23 Feb 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code F | $88K11,750 at $7.45 | filing |
| 17 Jan 2026filed 21 Jan 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code M | —75,000 | filing |
| 17 Jan 2026filed 21 Jan 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code F | $262K35,250 at $7.42 | filing |
| 17 Jan 2026filed 21 Jan 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —75,000 at $0.00 | filing |
| 17 Jan 2026filed 21 Jan 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —75,000 at $0.00 | filing |
| 17 Jan 2026filed 21 Jan 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code M | —75,000 | filing |
News
No headline names them, or the companies they trade most, lately.